Edition:
United Kingdom

Aetna Inc (AET.N)

AET.N on New York Stock Exchange

179.70USD
15 Dec 2017
Change (% chg)

$1.21 (+0.68%)
Prev Close
$178.49
Open
$178.30
Day's High
$180.62
Day's Low
$178.30
Volume
1,752,701
Avg. Vol
587,431
52-wk High
$192.37
52-wk Low
$116.05

Select another date:

Fri, Dec 8 2017

Photo

CVS expects U.S. Justice Department to handle review of Aetna deal

WASHINGTON CVS Health Corp expects the U.S. Justice Department to do the antitrust review of its planned acquisition of health insurer Aetna Inc, a spokesman for the drugstore chain operator said.

CVS expects Justice Department to handle review of Aetna deal

WASHINGTON CVS Health Corp expects the U.S. Justice Department to do the antitrust review of its planned acquisition of health insurer Aetna Inc, a spokesman for the drugstore chain operator said.

UPDATE 1-CVS expects U.S. Justice Department to handle review of Aetna deal

WASHINGTON, Dec 7 CVS Health Corp expects the U.S. Justice Department to do the antitrust review of its planned acquisition of health insurer Aetna Inc, a spokesman for the drugstore chain operator said.

CVS expects U.S. Justice Department to handle review of Aetna deal

WASHINGTON, Dec 7 U.S. drugstore chain operator CVS Health Corp expects the Justice Department to do the antitrust review of its planned acquisition of health insurer Aetna Inc, a spokesman said.

CVS likely wants FTC antitrust review, not Justice Department, of Aetna deal

WASHINGTON It is uncertain who in the U.S. government will carry out an antitrust review of CVS Health Corp's deal to buy health insurer Aetna Inc , but the drugstore company is likely hoping the potentially more lenient Federal Trade Commission gets the nod, antitrust experts say. | Video

BRIEF-CVS Says Co Would Be Required To Pay To Aetna Termination Fee Of $2.1 Bln If Merger Agreement Is Terminated

* CVS HEALTH CORP SAYS CO WOULD BE REQUIRED TO PAY TO AETNA A TERMINATION FEE OF $2.1 BILLION IF THE MERGER AGREEMENT IS TERMINATED - SEC FILING

CVS likely wants FTC antitrust review, not Justice Dept, of Aetna deal

WASHINGTON It is uncertain who in the U.S. government will carry out an antitrust review of CVS Health Corp's deal to buy health insurer Aetna Inc, but the drugstore company is likely hoping the potentially more lenient Federal Trade Commission gets the nod, antitrust experts say. | Video

CVS likely wants FTC antitrust review, not Justice Dept, of Aetna deal

WASHINGTON, Dec 5 It is uncertain who in the U.S. government will carry out an antitrust review of CVS Health Corp's deal to buy health insurer Aetna Inc, but the drugstore company is likely hoping the potentially more lenient Federal Trade Commission gets the nod, antitrust experts say.

BRIEF-Moody's says CVS-Aetna merger would have negative implications for other health care companies‍​

* Moody's: CVS-Aetna merger would have negative implications for other health care companies‍​ Source text: http://bit.ly/2BzpKdY Further company coverage:

CVS, Aetna executives defend $69 billion deal to skeptical Wall Street

NEW YORK CVS Health Corp and Aetna Inc said on Monday their $69 billion deal to combine the pharmacy and drug benefit manager and the No. 3 U.S. health insurer would transform healthcare and deliver cost savings, but investors took a pessimistic view of the combination in the short term. | Video

Select another date: